rewirebio.iobenchmarks
Dataset

122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)

Retrospective cohort from the First Affiliated Hospital, Sun Yat-sen University, February 2022 to February 2024.

Evaluation results

4 evaluations · 80 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
60.7% Accuracy (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 51.79 to 68.87

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-bstNGS against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-bstNGS', column 'Accuracy (95%CI)'
Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
17.4% Negative predictive value (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 9.09 to 30.72

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-bstNGS against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-bstNGS', column 'NPV (95%CI)'
Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
86.8% Precision (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 77.45 to 92.69

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-bstNGS against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-bstNGS', column 'PPV (95%CI)'
Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
63.5% Recall (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 53.88 to 72.08

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-bstNGS against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-bstNGS', column 'Sensitivity (95%CI)'
Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
44.4% Specificity (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 24.56 to 66.28

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-bstNGS against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-bstNGS', column 'Specificity (95%CI)'
Configuration: Conventional microbiological tests (Huang et al. 2026), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
54.9% Accuracy (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 46.07 to 63.46

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CMTs against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'CMTs', column 'Accuracy (95%CI)'
Configuration: Conventional microbiological tests (Huang et al. 2026), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
23.2% Negative predictive value (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 14.81 to 34.40

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CMTs against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'CMTs', column 'NPV (95%CI)'
Configuration: Conventional microbiological tests (Huang et al. 2026), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
96.2% Precision (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 87.25 to 98.96

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CMTs against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'CMTs', column 'PPV (95%CI)'
Configuration: Conventional microbiological tests (Huang et al. 2026), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
49% Recall (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 39.64 to 58.51

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CMTs against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'CMTs', column 'Sensitivity (95%CI)'
Configuration: Conventional microbiological tests (Huang et al. 2026), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
88.9% Specificity (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 67.20 to 96.90

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

CMTs against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'CMTs', column 'Specificity (95%CI)'
Configuration: Blood culture (Huang et al. 2026), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
22.9% Accuracy (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 16.38 to 31.17

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-culture only against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-culture only', column 'Accuracy (95%CI)'
Configuration: Blood culture (Huang et al. 2026), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
16.1% Negative predictive value (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 10.41 to 23.98

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-culture only against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-culture only', column 'NPV (95%CI)'
Configuration: Blood culture (Huang et al. 2026), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
100% Precision (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 72.25 to 100.00

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-culture only against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-culture only', column 'PPV (95%CI)'
Configuration: Blood culture (Huang et al. 2026), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
9.62% Recall (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 5.31 to 16.80

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-culture only against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-culture only', column 'Sensitivity (95%CI)'
Configuration: Blood culture (Huang et al. 2026), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
100% Specificity (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 82.41 to 100.00

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-culture only against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-culture only', column 'Specificity (95%CI)'
Configuration: Blood metagenomic NGS (Illumina NextSeq 550; Huang et al. 2026), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
39.3% Accuracy (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 31.13 to 48.21

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-mNGS against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-mNGS', column 'Accuracy (95%CI)'
Configuration: Blood metagenomic NGS (Illumina NextSeq 550; Huang et al. 2026), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
14.1% Negative predictive value (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 8.06 to 23.51

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-mNGS against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-mNGS', column 'NPV (95%CI)'
Configuration: Blood metagenomic NGS (Illumina NextSeq 550; Huang et al. 2026), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
84.1% Precision (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 70.63 to 92.07

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-mNGS against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-mNGS', column 'PPV (95%CI)'
Configuration: Blood metagenomic NGS (Illumina NextSeq 550; Huang et al. 2026), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
35.6% Recall (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 27.04 to 45.14

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-mNGS against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-mNGS', column 'Sensitivity (95%CI)'
Configuration: Blood metagenomic NGS (Illumina NextSeq 550; Huang et al. 2026), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
61.1% Specificity (patient level; all pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 38.62 to 79.70

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-mNGS against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'All pneumonia', row 'Blood-mNGS', column 'Specificity (95%CI)'
Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
73% Accuracy (patient level; fungal pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 64.46 to 80.04

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-bstNGS against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'Fungal pneumonia', row 'Blood-bstNGS', column 'Accuracy (95%CI)'
Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
71.4% Negative predictive value (patient level; fungal pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 62.46 to 78.98

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-bstNGS against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'Fungal pneumonia', row 'Blood-bstNGS', column 'NPV (95%CI)'
Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
90% Precision (patient level; fungal pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 59.58 to 98.21

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-bstNGS against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'Fungal pneumonia', row 'Blood-bstNGS', column 'PPV (95%CI)'
Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
21.9% Recall (patient level; fungal pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 12.00 to 36.71

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-bstNGS against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'Fungal pneumonia', row 'Blood-bstNGS', column 'Sensitivity (95%CI)'
Configuration: Geneplus broad-spectrum targeted NGS of microbial cell-free DNA (bstNGS), as run in Huang et al. 2026Protocol: Patient-level detection of causative pathogens in blood against the final clinical diagnosis (Huang et al. 2026 Table 2)
Dataset: 122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
98.8% Specificity (patient level; fungal pneumonia; reference: final clinical diagnosis)
percent · higher

Uncertainty: 95% CI 93.33 to 99.78

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

Blood-bstNGS against the final clinical diagnosis (Huang et al. 2026)

dna-pathogen-20261011-huang2026-protocol-clinical-diagnosis

Aggregation: Not reported

Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis · Table 2, stratum 'Fungal pneumonia', row 'Blood-bstNGS', column 'Specificity (95%CI)'

Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-10-22-1b7cf027e4f6 · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

8 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-10-22-1b7cf027e4f6
Property and statementOriginal source and locationReview and provenance
Access
Not stated in the inspected text
Context-only references
Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis

Original source ↗

Methods 'Sample enrollment and standard-of-care microbiology testing'; Results paragraph 1; Table 1

Version: Respiratory Research 27:357, published 2026-06-24; PMC13584460 full-text XML
Retrieved: 2026-10-11T22:07:38Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.access

Source artifact SHA-256: 79b237d733d9ad3af33722c30013afb0539adf03098ca1e1c2f18344bcc4a67d

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Denominator
122
Context-only references
Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis

Original source ↗

Methods 'Sample enrollment and standard-of-care microbiology testing'; Results paragraph 1; Table 1

Version: Respiratory Research 27:357, published 2026-06-24; PMC13584460 full-text XML
Retrieved: 2026-10-11T22:07:38Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.denominator

Source artifact SHA-256: 79b237d733d9ad3af33722c30013afb0539adf03098ca1e1c2f18344bcc4a67d

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Population
122 of 183 screened adults (61 excluded for missing paired samples or clinical information); 73.0% immunocompromised; blood tested by bstNGS, mNGS and culture from the same batch, BALF by mNGS
Context-only references
Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis

Original source ↗

Methods 'Sample enrollment and standard-of-care microbiology testing'; Results paragraph 1; Table 1

Version: Respiratory Research 27:357, published 2026-06-24; PMC13584460 full-text XML
Retrieved: 2026-10-11T22:07:38Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.population

Source artifact SHA-256: 79b237d733d9ad3af33722c30013afb0539adf03098ca1e1c2f18344bcc4a67d

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Source location
Methods 'Sample enrollment and standard-of-care microbiology testing'; Results paragraph 1; Table 1
Context-only references
Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis

Original source ↗

Methods 'Sample enrollment and standard-of-care microbiology testing'; Results paragraph 1; Table 1

Version: Respiratory Research 27:357, published 2026-06-24; PMC13584460 full-text XML
Retrieved: 2026-10-11T22:07:38Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 79b237d733d9ad3af33722c30013afb0539adf03098ca1e1c2f18344bcc4a67d

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Split
Single retrospective cohort; no split
Context-only references
Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis

Original source ↗

Methods 'Sample enrollment and standard-of-care microbiology testing'; Results paragraph 1; Table 1

Version: Respiratory Research 27:357, published 2026-06-24; PMC13584460 full-text XML
Retrieved: 2026-10-11T22:07:38Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.split

Source artifact SHA-256: 79b237d733d9ad3af33722c30013afb0539adf03098ca1e1c2f18344bcc4a67d

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Version
As described in Huang et al. 2026
Context-only references
Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis

Original source ↗

Methods 'Sample enrollment and standard-of-care microbiology testing'; Results paragraph 1; Table 1

Version: Respiratory Research 27:357, published 2026-06-24; PMC13584460 full-text XML
Retrieved: 2026-10-11T22:07:38Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: 79b237d733d9ad3af33722c30013afb0539adf03098ca1e1c2f18344bcc4a67d

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Description
Retrospective cohort from the First Affiliated Hospital, Sun Yat-sen University, February 2022 to February 2024.
Context-only references
Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis

Original source ↗

Methods 'Sample enrollment and standard-of-care microbiology testing'; Results paragraph 1; Table 1

Version: Respiratory Research 27:357, published 2026-06-24; PMC13584460 full-text XML
Retrieved: 2026-10-11T22:07:38Z

not individually reviewed

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 79b237d733d9ad3af33722c30013afb0539adf03098ca1e1c2f18344bcc4a67d

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Name
122 ICU patients with severe pneumonia-associated sepsis and paired blood and BALF (Huang et al. 2026)
Context-only references
Blood-based targeted sequencing of microbial cell-free DNA in severe pneumonia-associated sepsis

Original source ↗

Methods 'Sample enrollment and standard-of-care microbiology testing'; Results paragraph 1; Table 1

Version: Respiratory Research 27:357, published 2026-06-24; PMC13584460 full-text XML
Retrieved: 2026-10-11T22:07:38Z

not individually reviewed

No individual claim review recorded

Audit details

Field: name

Source artifact SHA-256: 79b237d733d9ad3af33722c30013afb0539adf03098ca1e1c2f18344bcc4a67d

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Sources and history

Release 2026-10-22-1b7cf027e4f6 · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: dna-pathogen-20261011-huang2026-data-sepsis122

areas
microbes-communities
contexts
clinical_research
version
As described in Huang et al. 2026
population
122 of 183 screened adults (61 excluded for missing paired samples or clinical information); 73.0% immunocompromised; blood tested by bstNGS, mNGS and culture from the same batch, BALF by mNGS
split
Single retrospective cohort; no split
denominator
122
access
Not stated in the inspected text
source locator
Methods 'Sample enrollment and standard-of-care microbiology testing'; Results paragraph 1; Table 1
Related records

Suggest a correction